Effect of COVID-19 Pandemic-Related Delays in Chemoembolization on the Survival of Patients with Hepatocellular Carcinoma

<div>Numbers of patients with hepatocellular carcinoma during the prelockdown (March to July 2019) and lockdown (March to July 2020) periods who underwent first transarterial chemoembolization (TACE) (a) and repeated TACE (b).</div>

Canadian Journal of Gastroenterology and Hepatology

fig1

Figure 1

Figure 1: Effect of COVID-19 Pandemic-Related Delays in Chemoembolization on the Survival of Patients with Hepatocellular Carcinoma 